S. Salmerón

523 total citations
31 papers, 232 citations indexed

About

S. Salmerón is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Psychiatry and Mental health. According to data from OpenAlex, S. Salmerón has authored 31 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 7 papers in Psychiatry and Mental health. Recurrent topics in S. Salmerón's work include Asthma and respiratory diseases (10 papers), Bipolar Disorder and Treatment (6 papers) and Respiratory and Cough-Related Research (4 papers). S. Salmerón is often cited by papers focused on Asthma and respiratory diseases (10 papers), Bipolar Disorder and Treatment (6 papers) and Respiratory and Cough-Related Research (4 papers). S. Salmerón collaborates with scholars based in France, Spain and Australia. S. Salmerón's co-authors include Catherine Coirault, D. S. Chemla, Yves Lecarpentier, F.–X. Blanc, P Duroux, Laurent Brochard, M. Henry‐Amar, Alain Tenaillon, Gérald Simonneau and Hervé Mal and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Applied Physiology and European Respiratory Journal.

In The Last Decade

S. Salmerón

25 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Salmerón France 8 137 94 76 34 27 31 232
François Lenfant France 9 153 1.1× 63 0.7× 96 1.3× 17 0.5× 91 3.4× 26 386
Andréa Lúcia Gonçalves da Silva Brazil 11 121 0.9× 39 0.4× 107 1.4× 31 0.9× 25 0.9× 44 269
Nuria Hernández Spain 5 295 2.2× 87 0.9× 32 0.4× 11 0.3× 25 0.9× 8 362
Vadim Leyenson United States 5 342 2.5× 50 0.5× 26 0.3× 21 0.6× 46 1.7× 6 424
Daniel Martínez Spain 6 88 0.6× 42 0.4× 42 0.6× 119 3.5× 19 0.7× 12 307
Aleksander Kania Poland 11 119 0.9× 139 1.5× 25 0.3× 17 0.5× 18 0.7× 31 255
Priscila A. Sperandio Brazil 12 258 1.9× 52 0.6× 220 2.9× 10 0.3× 24 0.9× 25 402
Rypko Beukema Netherlands 12 110 0.8× 43 0.5× 215 2.8× 48 1.4× 26 1.0× 26 384
Michael V. Genuardi United States 10 70 0.5× 48 0.5× 145 1.9× 15 0.4× 48 1.8× 41 270
Philip Moore United Kingdom 8 69 0.5× 32 0.3× 202 2.7× 7 0.2× 67 2.5× 15 289

Countries citing papers authored by S. Salmerón

Since Specialization
Citations

This map shows the geographic impact of S. Salmerón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Salmerón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Salmerón more than expected).

Fields of papers citing papers by S. Salmerón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Salmerón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Salmerón. The network helps show where S. Salmerón may publish in the future.

Co-authorship network of co-authors of S. Salmerón

This figure shows the co-authorship network connecting the top 25 collaborators of S. Salmerón. A scholar is included among the top collaborators of S. Salmerón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Salmerón. S. Salmerón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salmerón, S., Marc Valentí, Michael Berk, et al.. (2025). Beyond Highs and Lows: Unraveling Cannabis Withdrawal‐Induced Mania—A Two‐Year Observational Study of Hospital Admissions From 2015 to 2019. Acta Psychiatrica Scandinavica. 152(3). 193–202.
2.
3.
Giménez‐Palomo, Anna, et al.. (2024). Clinical, sociodemographic and environmental predicting factors for relapse in bipolar disorder: A systematic review. Journal of Affective Disorders. 360. 276–296. 2 indexed citations
4.
Bioque, Miquel, S. Salmerón, Borja García‐Bueno, et al.. (2024). Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis. Journal of Psychiatric Research. 172. 334–339. 7 indexed citations
5.
González-Díaz, Jairo M., Bernardo Sánchez‐Dalmau, Sílvia Amoretti, et al.. (2024). Retinal structure and its relationship with premorbid, clinical, and cognitive variables in young Spanish patients with early course schizophrenia spectrum disorders. European Neuropsychopharmacology. 92. 38–47. 1 indexed citations
6.
Salmerón, S., et al.. (2023). The silent waitress. A case report of mutism without catatonia. European Psychiatry. 66(S1). S627–S628.
7.
Yannoutsos, Alexandra, Gilles Châtellier, Diane Damotte, et al.. (2021). Patients with atherosclerotic peripheral arterial disease have a high risk of lung cancer: Systematic review and meta-analysis of literature. JMV-Journal de Médecine Vasculaire. 46(2). 53–65. 7 indexed citations
8.
Vervloët, D., et al.. (2014). Factors associated with poorly controlled asthma among adults in France. Revue française d'allergologie. 54(6). 428–437. 3 indexed citations
9.
Bigot, Frédéric, Loïc Verlingue, Stéphane Jouveshomme, et al.. (2013). Évolution épidémiologique du cancer broncho-pulmonaire en France et en Europe. Revue des Maladies Respiratoires Actualités. 5(5). 321–324. 1 indexed citations
10.
Teixeira, Luís, Emmanuelle Kempf, Stéphane Jouveshomme, et al.. (2012). Place des traitements ciblés dans la prise en charge des cancers broncho-pulmonaires. Pathologie Biologie. 60(4). 246–253. 1 indexed citations
11.
Salmerón, S., et al.. (2007). [The role of allergy in clinical course of asthma?].. PubMed. 24(8 Pt 3). 7S8–14. 1 indexed citations
12.
Salmerón, S.. (2005). ASUR - ASUR2 vers une standardisation de la prise en charge de l’Asthme aigu aux urgences. Revue des Maladies Respiratoires. 22(2). 30–31. 5 indexed citations
13.
Salmerón, S.. (2005). Mauvaise observance : quelles conséquences pour le patient asthmatique ?. Revue de Pneumologie Clinique. 61. 5–9. 1 indexed citations
14.
Salmerón, S., et al.. (2005). [ASUR-ASUR2: an overview of the standardisation of treatment of acute asthma in intensive care].. PubMed. 22(2 Pt 3). 4S30–1.
15.
Blanc, F.–X., et al.. (2003). Mechanics and crossbridge kinetics of tracheal smooth muscle in two inbred rat strains. European Respiratory Journal. 22(2). 227–234. 33 indexed citations
16.
Coirault, Catherine, et al.. (2000). [Biomechanics and bio-energetics of smooth muscle contraction. Relation to bronchial hyperreactivity].. PubMed. 17(2 Pt 2). 549–54. 5 indexed citations
17.
Chemla, D. S., Jean‐Louis Hébert, Catherine Coirault, et al.. (1996). Matching dicrotic notch and mean pulmonary artery pressures: implications for effective arterial elastance. American Journal of Physiology-Heart and Circulatory Physiology. 271(4). H1287–H1295. 39 indexed citations
18.
Salmerón, S., Laurent Brochard, Hervé Mal, et al.. (1994). Nebulized Versus Intravenous Albuterol in Hypercapnic Acute Asthma. A Multicenter, Double-Blind, Randomized Study. American Journal of Respiratory and Critical Care Medicine. 149(6). 1466–1470. 70 indexed citations
19.
Coirault, Catherine, et al.. (1994). Isometric relaxation of isolated diaphragm muscle: influence of load, length, time, and stimulation. Journal of Applied Physiology. 76(4). 1468–1475. 16 indexed citations
20.
Salmerón, S., et al.. (1993). Pneumopathie excavée révélatrice d'une pneumocystose. Médecine et Maladies Infectieuses. 23(12). 937–939.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by François Lenfant Breakdown of academic impact, for papers by Andréa Lúcia Gonçalves da Silva Breakdown of academic impact, for papers by Nuria Hernández Breakdown of academic impact, for papers by Vadim Leyenson Breakdown of academic impact, for papers by Daniel Martínez Breakdown of academic impact, for papers by Aleksander Kania Breakdown of academic impact, for papers by Priscila A. Sperandio Breakdown of academic impact, for papers by Rypko Beukema Breakdown of academic impact, for papers by Michael V. Genuardi Breakdown of academic impact, for papers by Philip Moore
Rankless by CCL
2026